Clinical Trials

Showing trials with last updates posted in 2022.

NCT02793583 | TERMINATED | PHASE2/PHASE3
710 participants

Study to Assess the Efficacy and Safety of Ublituximab + Umbralisib With or Without Bendamustine and Umbralisib Alone in Patients With Previously Treated Non-Hodgkins Lymphoma

Study Type:
INTERVENTIONAL
Last Updated:
2022-07-21
Start Date:
2016-05-25
Completion:
2022-05-31
Conditions
  • Diffuse Large B-Cell Lymphoma
  • Follicular Lymphoma
  • Marginal Zone Lymphoma
  • Mantle Cell Lymphoma
  • Small Lymphocytic Lymphoma
Interventions
  • BIOLOGICAL
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page